Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 204-207

  Hanemaaijer, Roeland ^a   Verheijen, Jan H ^a   Maguire, Teresa M ^c   Visser, Hetty ^a   Toet, Karin ^a   McDermott, Enda ^c   O'Higgins, Niall ^c   Duffy, Michael J ^b  

^a TNO   (Netherlands)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ARTICLE; BREAST TUMOR; CANCER INVASION; CLINICAL ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITOR COMPLEX; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY;

BREAST NEOPLASMS; CATALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROADENOMA; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROGNOSIS;

EID: 0034027920     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<204::AID-IJC9>3.0.CO;2-6     Document Type: Article

References (18)

1. AZNAVOORIAN, S. MURPHY, A.N., STETLER-STEVENSON, W.G. and LIOTTA, L.A., Molecular aspects of tumor cell invasion and metastasis. Cancer, 71, 1368-1383 (1993).
2. BROWN, P.D., BLOXIDGE, R.E., ANDERSON, E. and HOWELL, A., Expression of activated gelatinases in human invasive breast carcinomas. Clin. exp. Metastasis. 11, 183-189 (1993).
3. BROWN, P.D., Clinical studies with matrix metalloproteinase inhibitors. Acta pathol. microbiol. immunol. Scand., 107, 174-180 (1999)
4. CAPPER, S.J., VERHEIJEN, J., SMITH, L., SULLY, M., VISSER, H. and HANEMAAIJER, R., Determination of gelatinase-A (MMP-2) activity using a novel immunocapture assay. Ann. N.Y. Acad. Sci., 878, 487-490 (1999).
5. CARMELIET, P., MOONS, L., LIJNEN, R., BAES, M., LEMAITRE, V., TIPPING, P., DREW, A., EECKHOUT, Y., SHAPIRO, S., LUPU, F. and COLLEN, D., Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Genet., 17, 439-44 (1997).
6. CHAMBERS, A. and MATRISIAN, L., Changing views of the role of matrix metalloproteinases in metastasis. J. nat. Cancer Instit., 89, 1260-1270 (1997).
7. DAVIES, B., MILES, D.W., HAPPERSFIELD, L.C., NAYLOR, M.S., BOBROW, L.G., RUBENS, R.D. and BALKWILL, F.R., Activity of type IV collagenase in benign and malignant breast disease. Brit. J. Cancer, 67, 1126-1131 (1993).
8. DUFFY, M.J. and MCCARTHY, K., Matrix metalloproteinases in cancer: prognostic markers and targets for therapy. Int. J. Oncol., 12, 1343-1348 (1998).
9. HANEMAAIJER, R., VISSER, H., KONTTINEN, Y., KOOLWIJK, P. and VERHEIJEN, J.H., A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol., 17, 657-665 (1998).
10. KOSSAKOWSKA, A.E., HUCHCROFT, S.A., URBANSKI, S.J. and EDWARDS, D.R., Comparative analysis of the expression pattern of metalloprateinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Brit. J. Cancer. 73, 1401-1408 (1996).
11. LEE K.S., RHA S.Y., KIM S.J., KIM J.H., ROH J.K., KIM B.S., CHUNG H.C., Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin. exp. Metastasis, 14, 512-519 (1996)
12. MACDOUGAL, J.R. and MATRISIAN, L.M., Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev., 14, 351-362 (1995).
13. REMACLE, A., NOEL, A., DUGGAN, C., MCDERMOTT, E., O'HIGGINS, N., FOIDART, J.M. and DUFFY, M.J., Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Brit. J. Cancer, 77, 926-931 (1998).
14. SEIKI, M., SATO, H. and OKADA,Y., Membrane-type matrix metalloproteinase 1 (MTI-MMP) in cancer. Med. Aspects Proteases Protease Inhibitors. 15, 195-204 (1997).
15. SIER, C.F., KUBBEN, F.J., GANESH, S., HEERDING, M.M., GRIFFIOEN, G., HANEMAAIJER, R., VAN KRIEKEN, J.H., LAMERS, C.B. and VERSPAGET, H.W., Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Brit. J. Cancer, 74, 413-417 (1996).
16. TALVENSAAKI-MATTILA, A., PAAKKO, P., HOYHTYA, M., BLANCO-SEQUEIROS, G. and TURPEENNIEMI-HUJANEN, T., Matrix metalloproteinase-2 immunoreactive protein, a marker of aggressiveness in breast cancer. Cancer, 83, 1153-1162 (1998).
17. VERHEIJEN, J.H., NIEUWENBROEK, N.M.E., BEEKMAN, B., HANEMAAIJER, R., VERSPAGET, H.W., RONDAY, H.K. and BAKKER, A.H.F., Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. Biochem. J., 323, 603-609 (1997).
18. WOESSNER, J.F., Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB. J., 5, 2145-2154 (1991).